Related Experiment Video
Updated: Jun 17, 2026
14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
Chris C Tang1, Kathleen L Poston, Thomas Eckert
1Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
The Lancet. Neurology
|January 12, 2010
Summary
This study shows that metabolic brain imaging with spatial covariance analysis can accurately distinguish between idiopathic Parkinson's disease and related parkinsonian disorders. This technique aids in early diagnosis and patient selection for clinical trials.
Area of Science:
- Neurology
- Medical Imaging
- Biostatistics
Background:
- Idiopathic Parkinson's disease (IPD) shares symptoms with multiple system atrophy (MSA) and progressive supranuclear palsy (PSP).
- Accurate differentiation of these parkinsonian disorders is crucial for effective treatment and research.
Purpose of the Study:
- To evaluate the efficacy of fluorine-18-labelled-fluorodeoxyglucose-PET imaging combined with spatial covariance analysis in discriminating between IPD, MSA, and PSP.
- To develop an automated classification procedure for diagnosing parkinsonian disorders.
Main Methods:
- 167 patients with uncertain parkinsonian diagnoses underwent FDG-PET scans between 1998 and 2006.
- An automated image-based classification procedure using logistic regression and leave-one-out cross-validation was developed.
- Classification accuracy was compared against final clinical diagnoses made by blinded movement disorder specialists after a mean follow-up of 2.6 years.
Main Results:
- The image-based classification demonstrated high accuracy for all three conditions.
- For IPD: 84% sensitivity, 97% specificity, 98% PPV, 82% NPV.
- For MSA: 85% sensitivity, 96% specificity, 97% PPV, 83% NPV. For PSP: 88% sensitivity, 94% specificity, 91% PPV, 92% NPV.
Conclusions:
- Automated metabolic brain imaging offers high specificity in differentiating between parkinsonian disorders.
- This diagnostic tool can assist in early-stage treatment selection and recruitment for clinical trials.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...